(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Former microbiologist Darnisha Grant Harrison, CEO of Ennaid Therapeutics, on developing a technology that shows 99% effectiveness against the Zika virus, and the company's plans to be the first-to-market with a cure.
See omnystudio.com/listener for privacy information.
